...
首页> 外文期刊>Case Reports in Medicine >Senile Systemic Amyloidosis Presenting as Hematuria: A Rare Presentation and Review of Literature
【24h】

Senile Systemic Amyloidosis Presenting as Hematuria: A Rare Presentation and Review of Literature

机译:患有血尿的老年人全身淀粉样蛋白症:文学的罕见介绍和审查

获取原文

摘要

Introduction. Senile systemic amyloidosis is a multisystem disease where wild-type insoluble transthyretin (ATTRwt) protein gets deposited in the tissues leading to organ dysfunction. Methodology. We present the case of a patient who presented with hematuria and bladder involvement by ATTRwt amyloidosis who ultimately died of multiorgan failure. Results. The patient was an 82-year-old white male with a history of ischemic cardiomyopathy (ejection fraction (EF): 20–25%), chronic atrial fibrillation, chronic kidney disease (CKD), and carpal tunnel syndrome who presented with acute hematuria, urinary retention, and progressive fatigue. He underwent cystoscopy and bladder biopsy which was positive on congo-red stain diagnostic for amyloidosis. Echocardiogram demonstrated worsening of EF to 10–15% and concentric left ventricle hypertrophy. MRI was not performed due to underlying CKD. His condition deteriorated during the hospital stay, and he developed cardiogenic shock and progressive liver dysfunction. Infectious workup was negative. Meanwhile, the biochemical investigations (serum protein electrophoresis, immunofixation, and urine kappa/lambda chains) ruled out plasma cell dyscrasias. Mass spectrometry analysis of the bladder biopsy specimen confirmed wild-type transthyretin (ATTRwt) amyloidosis consistent with senile systemic amyloidosis. Due to patients’ extremely poor prognosis, his family wished to focus on patient’s comfort-oriented measures only, and patient passed away shortly thereafter. Conclusion. Senile systemic amyloidosis can rarely present in an atypical fashion such as hematuria. The treatment options are limited in this disease process. Novel therapies are in the early phases of development. Concern also exists that in patients with multiple comorbidities, this entity is under recognized until the more advanced stages.
机译:介绍。老年人的全身淀粉样蛋白化是一种多系统疾病,其中野生型不溶性ransthyretin(Attrwt)蛋白被沉积在导致器官功能障碍的组织中。方法。我们展示了患有血尿和膀胱患者的患者的患者,该患者受到最终死于多功能衰竭的attrwt淀粉样式症状的患者。结果。患者是一名82岁的白人男性,缺血性心肌病史(射血分数(EF):20-25%),慢性心房颤动,慢性肾脏疾病(CKD),以及患有急性血尿的腕管综合征,尿潴留,渐进疲劳。他接受了膀胱镜检查和膀胱活检,其在氨基型症的刚果红染色诊断上是阳性的。超声心动图表明EF至10-15%的恶化,同心左心室肥大。由于CKD底层,未执行MRI。他的病情在住院期间恶化,他开发了心形成休克和进步性肝功能障碍。传染性余处是消极的。同时,生物化学研究(血清蛋白电泳,免疫混膜和尿kappa / lambda链)排除了血浆细胞功能筛查。膀胱活检标本的质谱分析证实野生型Transthyretin(Attrwt)淀粉样蛋白病与老年人的全身淀粉样蛋白症。由于患者的预后极差,他的家庭希望专注于患者的患者的舒适导向措施,患者在此后不久传递。结论。老年人的全身淀粉样蛋白症可以很少以血尿等异质方式存在。该疾病过程中的治疗方案受到限制。新的疗法处于发展的早期阶段。令人担忧还存在,在多种合并症的患者中,在更高级的阶段之前,该实体处于公认。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号